The Mucin (MUC) family, a range of highly glycosylated macromolecules, is ubiquitously
expressed in mammalian epithelial cells. Such molecules are pivotal in establishing …

Immunotherapies hold immense potential for achieving durable potency and long-term
survival opportunities in cancer therapy. As vital biological mediators, peptides with high …

The efficacy of conventional treatments for pancreatic cancer remains unsatisfactory, and
immunotherapy is an emerging option for adjuvant treatment of this highly deadly disorder …

High‐frequency mutation of the TP53 tumor suppressor gene is observed in multiple human
cancers, which promotes cancer progression. However, the mutated gene‐encoded protein …

Tumor immunotherapy has now become one of the most potential therapy for those
intractable cancer diseases. The antigens on the cancer cell surfaces are the keys for the …

Tumor necrosis factor receptor (TNFR)-associated factor 6 (TRAF6) signaling is a critical
positive mechanism for the development, homeostasis and activation of immune cells. We …

Background The downregulation of miRNA-485-5-p was related to prognosis of various
cancers, including hepatocellular carcinoma (HCC), while MUC1 was aberrantly expressed …